The REDEFINE 1 trial found that when evaluating the treatment effect regardless of whether patients stayed on treatment, those treated with CagriSema achieved weight loss of 20.4% (from an average baseline body weight of 236 lb) at 68 weeks versus 3.0% (from an average baseline body weight of 235 lb) for the placebo group which was statistically significant
Hair related effects often take 3 to 6 months
According to the authors, the funders had no role in the study's design, data collection, analysis, interpretation, manuscript preparation, review, approval, or publication decisions
Children to manage
Their use in this context represents off-label prescribing, which requires careful clinical justification and informed patient consent
Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009-2019